Skip to Content

Bayer AG ADR BAYRY Stock Quote

| Rating as of


Market Closed

| Currency in USD

  • Last Close 12.67
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Large Value
  • Day Range 12.65  –  12.79
  • Year Range 11.41  –  17.00
  • Market Cap 49.7893 Bil
  • Volume / Avg 312,503.0 /  823,248.7
  • Price / Sales 0.98
  • Price / Book 1.24
  • Forward Div Yield 4.84%
  • Trailing Div Yield 5.21%

Morningstar‘s Stock Analysis BAYRY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Bayer's Wide Portfolio of Drug and Crop Science Products Should Enable Steady Long-Term Cash Flows

Damien Conover Sector Director

Business Strategy and Outlook

| Damien Conover |

Largely on the basis of the strong competitive advantages of the healthcare group and to a lesser extent the crop science business, we believe Bayer has created a wide economic moat. Also, the past divestiture of no-moat material science group Covestro leaves the company in a stronger competitive position.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics BAYRY

Company Profile BAYRY

Business Description

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Kaiser-Wilhelm-Allee 1
Leverkusen, NW, 51368, DEU
Industry Drug Manufacturers - General
Employees 102,048

Related Articles BAYRY

Competitors & Peers BAYRY

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of BAYRY’s competitive advantage.

Bayer AG ADR


Bristol-Myers Squibb Co


Pfizer Inc


Basf SE

$0.00 (0.00%) −$0.18 (0.30%) −$0.16 (0.49%) −$0.38 (0.87%)
Market Cap
49.79 Bil123.05 Bil184.57 Bil38.45 Bil
Drug Manufacturers - General Drug Manufacturers - General Drug Manufacturers - General Chemicals
Basic Materials

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Bayer AG ADR Stock

Yes. BAYRY has a forward dividend yield of 5.21%. See BAYRY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

BAYRY’s market cap is 49.79 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

BAYRY’s stock style is Large Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

BAYRY’s price/sales is 0.98.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

BAYRY’s price/forward earnings is 32.73.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

BAYRY’s price/book is 1.24.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See BAYRY’s valuation ratios compared to the Market Index.

BAYRY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare BAYRY’s historical performance against its industry peers and the overall market.